Rachel Kathleen Ashby, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Luteal Phase | 1 | 2011 | 138 | 0.370 |
Why?
|
| Fertilization in Vitro | 6 | 2022 | 1301 | 0.330 |
Why?
|
| Oocyte Retrieval | 2 | 2018 | 162 | 0.220 |
Why?
|
| Social Support | 1 | 2011 | 2191 | 0.190 |
Why?
|
| Insurance | 1 | 2022 | 115 | 0.180 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 104 | 0.170 |
Why?
|
| Infertility | 2 | 2021 | 655 | 0.170 |
Why?
|
| Pregnancy Rate | 4 | 2022 | 654 | 0.150 |
Why?
|
| Opportunistic Infections | 1 | 2021 | 377 | 0.150 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2022 | 503 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4528 | 0.130 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2018 | 274 | 0.120 |
Why?
|
| Rheumatology | 1 | 2021 | 602 | 0.120 |
Why?
|
| Public Opinion | 1 | 2017 | 483 | 0.110 |
Why?
|
| Fertility | 1 | 2017 | 768 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2018 | 865 | 0.100 |
Why?
|
| Tissue Banks | 1 | 2011 | 183 | 0.090 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 118 | 0.090 |
Why?
|
| Embryo Transfer | 1 | 2014 | 526 | 0.080 |
Why?
|
| Sperm Count | 1 | 2010 | 227 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2021 | 2776 | 0.080 |
Why?
|
| Progesterone | 1 | 2014 | 751 | 0.080 |
Why?
|
| Sperm Motility | 1 | 2010 | 264 | 0.080 |
Why?
|
| Oocyte Donation | 1 | 2009 | 52 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2018 | 1379 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3425 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 2152 | 0.070 |
Why?
|
| Semen | 1 | 2010 | 353 | 0.070 |
Why?
|
| Infertility, Male | 1 | 2010 | 394 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 731 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 1293 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1673 | 0.060 |
Why?
|
| Oocytes | 2 | 2022 | 1167 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 2924 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2014 | 2393 | 0.060 |
Why?
|
| Leukemia | 1 | 2011 | 1523 | 0.050 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2003 | 65 | 0.050 |
Why?
|
| Pregnancy, Ectopic | 1 | 2003 | 146 | 0.050 |
Why?
|
| Pregnancy | 5 | 2022 | 30215 | 0.040 |
Why?
|
| Motor Activity | 1 | 2010 | 2705 | 0.040 |
Why?
|
| Emotions | 1 | 2011 | 2759 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 893 | 0.030 |
Why?
|
| Methotrexate | 1 | 2003 | 1720 | 0.030 |
Why?
|
| Estradiol | 2 | 2014 | 1946 | 0.030 |
Why?
|
| Religion | 1 | 2017 | 375 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2017 | 727 | 0.020 |
Why?
|
| Adult | 7 | 2018 | 223055 | 0.020 |
Why?
|
| Female | 9 | 2022 | 396050 | 0.020 |
Why?
|
| Robotics | 1 | 2018 | 807 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 14062 | 0.020 |
Why?
|
| Maternal Age | 1 | 2014 | 804 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3199 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11855 | 0.020 |
Why?
|
| Young Adult | 3 | 2011 | 59849 | 0.020 |
Why?
|
| Fertility Agents, Female | 1 | 2009 | 101 | 0.020 |
Why?
|
| Bicycling | 1 | 2010 | 176 | 0.020 |
Why?
|
| Ovulation | 1 | 2009 | 178 | 0.020 |
Why?
|
| Adolescent | 2 | 2017 | 88794 | 0.020 |
Why?
|
| Ovulation Induction | 1 | 2009 | 276 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 2009 | 457 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2018 | 5302 | 0.020 |
Why?
|
| Humans | 10 | 2022 | 765823 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8320 | 0.020 |
Why?
|
| Middle Aged | 3 | 2017 | 223016 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13266 | 0.010 |
Why?
|
| Overweight | 1 | 2014 | 2443 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2003 | 553 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 74853 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24278 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2014 | 65223 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10723 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12056 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4849 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72896 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81505 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18380 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40109 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 41643 | 0.000 |
Why?
|
| Male | 2 | 2017 | 363740 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2010 | 54798 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7416 | 0.000 |
Why?
|
| Aged | 1 | 2017 | 171178 | 0.000 |
Why?
|